<DOC>
	<DOC>NCT00189267</DOC>
	<brief_summary>The purpose of the study is to compare effectiveness and safety of multiple applications of imiquimod 5% cream and vehicle cream in graft recipients suffering from actinic keratosis.</brief_summary>
	<brief_title>A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Have a total of 410 actinic keratosis (AK) lesions located on either face or scalp If female and of childbearing potential, have a negative urine pregnancy test at treatment initiation, and willing to use a medically acceptable method of contraception during the treatment period Renal, liver or heart transplant recipients Graft rejection with loss of the graft in the medical history Unstable status of organ transplant disease during the last 12 months Known to be pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Aldara</keyword>
	<keyword>Actinic Keratosis</keyword>
	<keyword>Graft Recipients</keyword>
</DOC>